Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH)
Study sponsor: AKARI Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2018-03-20Actual
Enrollment · participants1Actual
Source updated2023-07-12Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.